top of page
Image by Tron Le
Vietnam Pharmaceutical Registration

Your DAV Gateway

Regulatory . Certification . Licensing . Assurance

Navigate Vietnam's rapidly growing US$10 billion pharmaceutical market with expert local guidance. Our Vietnam-based team provides comprehensive DAV registration services to capture opportunities in this import-dominant market where 60% of pharmaceuticals are imported, valued at US$6 billion and projected to reach US$9.66 billion by 2026.

Why Vietnam

Exceptional Growth in Import-Dominant Pharmaceutical Market

Rapid Market Growth & Import Opportunities

As of 2020, the Vietnamese pharmaceutical market was valued at approximately US$10 billion, showcasing rapid growth and substantial potential for both local and imported drugs.

 

Import Market Dominance:

• Approximately 60% of pharmaceutical end products in Vietnam are imported

• Import market constitutes approximately US$6 billion in 2020

• Anticipated growth reaching US$9.66 billion by 2026

• Strong market credibility and desirability for imported pharmaceuticals

Market Structure & Opportunities

The Vietnamese pharmaceutical landscape presents unique opportunities

Regulatory Affairs Vietnam
Marketing Authorization Vietnam

Local vs. Import Balance:

• 60% imported pharmaceuticals demonstrating market openness

• 40% locally produced drugs complementing the market

• Import dominance elevating credibility and desirability of international pharmaceutical brands

• Strong consumer confidence in imported pharmaceutical products

Regulatory Framework Structure

The regulatory framework is overseen by the Drug Administration of Vietnam (DAV) under the Ministry of Health, ensuring comprehensive oversight of:

 

DAV Regulatory Responsibilities:

• Safety, efficacy, and quality control for all pharmaceutical products

• Marketing authorization and product registration processes

• Import licensing and compliance monitoring

• Post-market surveillance and pharmacovigilance

Regulatory Challenges & Modernization

However, navigating regulatory processes poses certain challenges:

 

Current Regulatory Environment:

• Bureaucratic hurdles requiring expert navigation

• Prolonged timelines within the DAV system

• Complex documentation and submission requirements

• Potential delays that may hinder timely product innovations

Market Structure & Opportunities

• Striking balance between affordability and drug safety remains a persistent challenge

• Ongoing modernization efforts to improve regulatory efficiency

• Government commitment to streamlining approval processes

• Technological integration initiatives to reduce bureaucratic barriers

Compliance Vietnam

Ready to Enter Vietnam's US$10 Billion Pharmaceutical Market?

Let's Navigate Your DAV Registration Success

Don't let regulatory complexity delay your entry into Vietnam's rapidly growing pharmaceutical market. Our Vietnam-based regulatory experts, with deep DAV knowledge and proven track record, are ready to accelerate your market access in this import-dominant market projected to reach US$9.66 billion by 2026.

 

Contact us today to discuss how our Vietnam expertise can unlock opportunities in Southeast Asia's fastest-growing pharmaceutical market.

bottom of page